Dynavax Technologies Corp (DVAX)

5.00
NASDAQ : Health Care
Prev Close 5.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 3.20 / 29.86
Avg Volume 2.01M
Exchange NASDAQ
Shares Outstanding 38.53M
Market Cap 200.34M
EPS -3.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Oversold Conditions For Dynavax Technologies (DVAX)

Oversold Conditions For Dynavax Technologies (DVAX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

INVESTOR ALERT: Goldberg Law PC Announces The Filing Of A Securities Class Action Lawsuit Against Dynavax Technologies Corporation And Encourages Investors With Losses To Contact The Firm

INVESTOR ALERT: Goldberg Law PC Announces The Filing Of A Securities Class Action Lawsuit Against Dynavax Technologies Corporation And Encourages Investors With Losses To Contact The Firm

Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Dynavax Technologies Corporation ("Dynavax" or the "Company") (Nasdaq: DVAX).

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Dynavax Technologies Corporation

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Dynavax Technologies Corporation

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Dynavax Technologies Corporation securities (NASDAQ:DVAX) from March 10, 2014 through November 11,...

Dow Scores Slim New Record While Nasdaq, S&P 500 Fall

Dow Scores Slim New Record While Nasdaq, S&P 500 Fall

The Dow ekes out slim gains to score a new record on Monday.

Stocks Waver as Wall Street's Trump Rally Fades

Stocks Waver as Wall Street's Trump Rally Fades

Stocks hold mixed midday Monday as Wall Street continues to pick apart the likely policies of President-elect Donald Trump.

Dynavax Shares Plunge on Rejected Application

Dynavax Shares Plunge on Rejected Application

Shares of the drugmaker were falling on news that U.S. regulators have rejected its Heplisav-B application

How to Trade Monday's Most Active Stocks - Facebook, Dynavax, Barrick Gold, More

How to Trade Monday's Most Active Stocks - Facebook, Dynavax, Barrick Gold, More

Here's a technical look at how to trade some of the most active stocks on the market right now.

Midday Report: Dynavax Slumps on FDA Rejection; U.S. Stocks Fluctuate

Midday Report: Dynavax Slumps on FDA Rejection; U.S. Stocks Fluctuate

U.S. stocks fluctuate as Wall Street picks apart the likely policies of President-elect Donald Trump.

Noteworthy Monday Option Activity: DVAX, GLPI, HRTX

Noteworthy Monday Option Activity: DVAX, GLPI, HRTX

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Dynavax Technologies Corp , where a total volume of 15,765 contracts has been traded thus far today, a contract volume which is representative of approximately 1.6 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 168.2% of DVAX's average daily trading volume over the past month, of 937,270 shares.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud Violations By Certain Officers And Directors Of Dynavax Technologies Corporation

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud Violations By Certain Officers And Directors Of Dynavax Technologies Corporation

Levi & Korsinsky announces it has commenced an investigation of Dynavax Technologies Corporation ("Dynavax" or the "Company") (NASDAQ: DVAX) concerning possible violations of federal securities laws by certain officers...

Stocks Fluctuate as Wall Street Picks Apart Trump's Policies

Stocks Fluctuate as Wall Street Picks Apart Trump's Policies

Stocks hold mixed on Monday as Wall Street continued to pick apart the likely policies of President-elect Donald Trump.

Dynavax Shares Fall on FDA Rejection of Hepatitis B Vaccine

Dynavax Shares Fall on FDA Rejection of Hepatitis B Vaccine

Dynavax now says it will need assistance from another drug company or financial partner to resubmit Heplisav-B for another shot at approval.

Dynavax Technologies Stock Sees Short Interest Increase 10.3%

Dynavax Technologies Stock Sees Short Interest Increase 10.3%

The most recent short interest data has been released for the 10/31/2016 settlement date, which shows a 1,081,158 share increase in total short interest for Dynavax Technologies Corp , to 11,523,545, an increase of 10.35% since 10/14/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Notable Wednesday Option Activity: DVAX, GTY, ENH

Notable Wednesday Option Activity: DVAX, GTY, ENH

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Dynavax Technologies Corp , where a total volume of 9,981 contracts has been traded thus far today, a contract volume which is representative of approximately 998,100 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 50% of DVAX's average daily trading volume over the past month, of 2.0 million shares.

FDA Precedent Suggests Dynavax Hep B Vaccine Faces High Rejection Risk

FDA Precedent Suggests Dynavax Hep B Vaccine Faces High Rejection Risk

The FDA's pattern could be trouble for Dynavax' vaccine.

New 52-Week Low Could Prompt More Insider Buying At DVAX

New 52-Week Low Could Prompt More Insider Buying At DVAX

In trading on Friday, shares of Dynavax Technologies Corp touched a new 52-week low of $10.11/share. That's a $19.75 share price drop, or -66.14% decline from the 52-week high of $29.86 set back on 01/08/2016.

Biotech Stock Mailbag: Dynavax, Puma, Ariad

Biotech Stock Mailbag: Dynavax, Puma, Ariad

TheStreet's Adam Feuerstein answers reader questions about biotech stocks.

5 Stocks to Trade for Big Breakout Gains

5 Stocks to Trade for Big Breakout Gains

These five stocks could be toxic for your portfolio in the month ahead.

'Mad Money' Lightning Round: I Don't Care for Cabela's

'Mad Money' Lightning Round: I Don't Care for Cabela's

Cramer says wait for Cypress Semiconductor to come down more and stay away from Ryerson.

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week

The risks of a September interest rate hike are now too great to be ignored, Cramer says.

4 Biotechs Set to Provide a Shot in the Arm

4 Biotechs Set to Provide a Shot in the Arm

Each company has approaching catalysts.

4 Biotechs Set to Provide a Shot in the Arm

4 Biotechs Set to Provide a Shot in the Arm

Each company has approaching catalysts.

Here's a Reason Why Dynavax Technologies (DVAX) Stock Is Soaring Today

Here's a Reason Why Dynavax Technologies (DVAX) Stock Is Soaring Today

William Blair said on Tuesday that the FDA's decision to cancel a November advisory meeting for Dynavax Technologies' (DVAX) hepatitis B vaccine could be beneficial to the company.

How to Play It When the FDA Slams Your Stock

How to Play It When the FDA Slams Your Stock

Here are three recent examples of how the patient can profit.